Management of Renal and Visceral Arterial Stenoses

  • M. G. Cowling
Part of the Medical Radiology book series (MEDRAD)


The two most common causes for renal artery stenosis are fibromuscular dysplasia (FMD) and atheromatous renal artery stenosis (ARAS). FMD may cause uncontrolled hypertension, usually in younger patients, and is amenable to treatment with balloon angioplasty. ARAS is a more complex disorder and does not always require treatment. However, where therapy is required it is generally best treated by the insertion of a balloon expandable stent. Visceral arterial stenoses causing symptomatic gut ischaemia are relatively uncommon, but can be successfully treated with angioplasty or stent insertion.


Renal Artery Renal Artery Stenosis Stent Insertion Nephrogenic Systemic Fibrosis Fibromuscular Dysplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. AbuRahma AF, Stone PA, Bates MC et al (2003) Angioplasty/stenting of the superior mesenteric artery and celiac trunk: early and late outcomes. J Endovasc Ther 10:1046–1053PubMedCrossRefGoogle Scholar
  2. Allen RC, Martin GH, Rees CR et al (1996) Mesenteric angioplasty in the treatment of chronic intestinal ischaemia. J Vasc Surg 24:415–421PubMedCrossRefGoogle Scholar
  3. The ASTRAL trial investigators (2009) Revascularization versus best edical therapy for renal artery stenosis. N Engl J Med 361:1953–1962Google Scholar
  4. Bax L, Arend-Jan J, Wolltlez MD et al (2009) Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function. Ann Int Med 150:840–850PubMedGoogle Scholar
  5. Birrer M, Do DD, Mahler F et al (2002) Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 23:146–152PubMedCrossRefGoogle Scholar
  6. Brawn LA, Ramsey LE (1987) Is “improvement” real with percutaneous transluminal angioplasty in the management of renovascular hypertension? Lancet 2(8571):1313–1316PubMedCrossRefGoogle Scholar
  7. Chahi T, Alfidja AT, Biard M et al (2004) Endovascular treatment of chronic mesenteric ischemia: results in 14 patients. Cardiovasc Intervent Radiol 27:637–642CrossRefGoogle Scholar
  8. Cicuto KP, McLean GK, Oleaga JA et al (1981) Renal artery stenosis: anatomical classification for percutaneous transluminal angioplasty. Am J Roentgenol 137:599–601Google Scholar
  9. Dorros G, Jaff M, Jain A et al (1995) Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 75:1051–1055PubMedCrossRefGoogle Scholar
  10. Fioole B, van de Rest HJ, Maijer JR et al (2010) Percutaneous transluminal angioplasty and stenting as first choice treatment in patients with chronic mesenteric ischaemia. J Vasc Surg 51:386–391PubMedCrossRefGoogle Scholar
  11. Flechner SM (1984) Percutaneous transluminal dilatation: a realistic appraisal in patients with stenosing lesions of the renal artery. Urol Clin North Am 11:515–527PubMedGoogle Scholar
  12. Fleischmann D (2003) MDCT of renal and mesenteric vessels. Eur Radiol 13(Suppl 5):M94–M101PubMedGoogle Scholar
  13. Harden PN, MacLeod MJ, Rodger RSC et al (1997) Effect of renal artery stenting on progression of renovascular renal failure. Lancet 349:1133–1136PubMedCrossRefGoogle Scholar
  14. Hoffman O, Carreres T, Sapoval MR et al (1998) Ostial renal artery stenosis angioplasty: immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol 9:65–73PubMedCrossRefGoogle Scholar
  15. Odurney A, Sniderman KW, Colapinto RF (1988) Intestinal angina: percutaneous transluminal angioplasty of celiac and superior mesenteric arteries. Radiology 167:59–62Google Scholar
  16. Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362PubMedCrossRefGoogle Scholar
  17. Matsumoto AH, Tegtmeyer CJ, Fitzgerald EK et al (1995) Percutaneous transluminal angioplasty of visceral arterial stenoses: results and long-term clinical follow-up. J Vasc Interv Radiol 6:165–174PubMedCrossRefGoogle Scholar
  18. Moss JG, Hamilton G (2000) Renal and visceral artery intervention. In: Dyet JF, Nicholson AA, Ettles DF, Wilson SE (eds) Textbook of endovascular procedures. Churchill Livingston, Philadelphia, pp 151–173Google Scholar
  19. Raza SA, Chugtai AR, Wahba M et al (2004) Multislice CT angiography in renal artery stent evaluation: prospective comparison with intra-arterial digital subtraction angiography. CVIR 27:9–15PubMedCrossRefGoogle Scholar
  20. Resch T, Lindh M, Dias M et al (2005) Endovascular recanalisation in occlusive mesenteric ischemia—feasability and early results. Eur J Vasc Endovasc Surg 29:199–203PubMedCrossRefGoogle Scholar
  21. Rountas C, Vlychou M, Vassiou K et al (2007) Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography and digital subtraction angiography. Ren Fail 29:295–302PubMedCrossRefGoogle Scholar
  22. Sharafuddin MJ, Olson CH, Sun S et al (2003) Eondovascular treatment of celiac and mesenteric aerteries stenoses: applications and results. J Vasc Surg 38:692–698PubMedCrossRefGoogle Scholar
  23. Simonetti G, Lupatelli L, Urigo F et al (1992) Interventional radiology in the treatment of acute and chronic mesenteric ischaemia. Radiol Med 84:98–105PubMedGoogle Scholar
  24. Sos TA, Pickering TG, Sniderman K et al (1983) Percutaneous transluminal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 309:274–279PubMedCrossRefGoogle Scholar
  25. Surowiec SM, Sivamurthy N, Rhodes JM et al (2003) Percutaneous therapy for renal fibromuscular dysplasia. Ann Vasc Surg 17:650–655PubMedCrossRefGoogle Scholar
  26. Tegtmeyer CJ, Selby JB, Hartwell S et al (1991) Results and complications of angioplasty in fibromuscular disease. Circulation 83(2 Suppl):I115–I161Google Scholar
  27. Tegtmeyer CJ, Matsumoto AH, Angle JF (1996) Percutaneous transluminal angioplasty in fibrous dysplasia and children. In: Novick A, Scoble J, Hamilton G (eds) Renal vascular disease, 1st edn. WB Saunders, London, pp 363–383Google Scholar
  28. Trinquart L, Mounier-Vehier C, Sapoval M et al (2010) Efficacy of revascularisation for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 56:525–532PubMedCrossRefGoogle Scholar
  29. van de Ven PGJ, Beutler JJ, Kaatee R et al (1995) Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 346:672–674PubMedCrossRefGoogle Scholar
  30. van de Ven PGJ, Kaatee R, Beutler JJ et al (1999) Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 353:282–286PubMedCrossRefGoogle Scholar
  31. Zhang H, Prince MR (2004) Renal MR angiography. Magn Reson Imaging Clin N Am 12:487–503PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  1. 1.University Hospital of North Staffordshire NHS TrustStoke-on-TrentUK

Personalised recommendations